News
Brief news reports on Tuberculosis
By
PLOS
Published: July 4, 2014, 5:47 p.m.·
Tags:
Scientific research
A third of the global population is infected with the bacterial pathogen, a mycobacterium, that causes tuberculosis (TB). Most carriers control the infection and are asymptomatic, but severe forms of the disease (more common in children and immune-compromised adults, and often caused by particularly aggressive—or hypervirulent—mycobacterial strains) kill over a million people every year. An article published on July 3rd in PLOS Pathogens now identifies a factor made by the host that exacerbates lung damage in severe TB. The results also suggest why gene mutations that render the factor inactive are common.
Read More →
By
Brook Baker
Published: July 4, 2014, 5:32 p.m.·
Tags:
Access,
Drug-resistant TB
Médecins Sans Frontières has obtained an important but long-delayed victory in a a challenge to the refusal of the Medicines Control Council in South Africa to issue section 21 permission allowing the temporary importation and patient use of a generic version of a key, tuberculosis medicine, linezolid. Linezolid can be effectively used as a treatment of drug-resistant tuberculosis, but the private sector cost of taking one pill a day for two years was approximately $49,000 when the medicine was sourced from the brand-name patent holder, Pfizer, at $65/pill. Generic versions of linezolid are manufactured in India by Hetero at significantly reduced cost of only $8/pill.
Read More →
By
Kelly Grant
Published: July 4, 2014, 5:24 p.m.·
Tags:
Global TB response,
TB epidemiology,
TB programs
The World Health Organization is ramping up its efforts to wipe out tuberculosis in countries with low rates of active TB by setting a goal of eradicating the disease by 2050 in 33 countries, including Canada.
Read More →
By
Jonathan Stillo
Published: July 3, 2014, 10:23 p.m.·
Tags:
Treatment,
Access,
Drug-resistant TB,
TB programs,
Advocacy
For Romanians with XDR-TB, except for the lucky few who get on a bus or a plane and become medical refugees, throwing themselves at the mercy of other European countries, someday never comes.
Read More →
By
Romanian Angel Appeal Foundation,
Association for MDR-TB Patients Support
Published: July 3, 2014, 9:50 p.m.·
Tags:
TB epidemiology
The Romanian Angel Appeal Foundation and the Association for MDR-TB Patients Support conducted in February – March a survey among Romanian TB and MDR-TB patients, their families and specialists working in the field, in order to pinpoint the patients’ social, psychological and medical needs. The survey report was published in June and it shows the main needs reported by patients or identified by the professionals who work with them.
Read More →
By
World Health Organization,
European Respiratory Society
Published: July 3, 2014, 8:20 p.m.·
Tags:
Global TB response
WHO and the European Respiratory Society present a new framework to eliminate tuberculosis in countries with low levels of the disease.
Read More →
By
Economist Intelligence Unit
Published: July 3, 2014, 10:38 a.m.·
Tags:
Global TB response,
Advocacy
A new report on tuberculosis calls for raising the profile of TB, fight apathy and lack of compelling ambition in addressing the disease.
Read More →
By
Médecins Sans Frontières
Published: July 2, 2014, 11:14 a.m.·
Tags:
Advocacy,
Treatment,
Access,
Drug-resistant TB
Patients & MSF doctors elated as MCC approval for Médecins Sans Frontières to use generic linezolid paves the way for national registration and access.
Read More →
By
African Union
Published: July 2, 2014, 10:39 a.m.·
Tags:
Global TB response
Malabo, Equatorial Guinea 27 June 2014: More than 50 African Heads of State and Government committed Friday to work together to sustain efforts to defeat AIDS, tuberculosis (TB) and malaria on the continent. With major commitments including the Abuja Declaration and the African Union Roadmap ending in 2015 leaders emphasised the need to remain focused on ensuring the gains made, will be sustained and that Africa moves towards fully controlling the three epidemics.
Read More →
By
Weill Cornell Medical College
Published: July 2, 2014, 10:16 a.m.·
Tags:
Scientific research
Scientists have long worked to understand why antibiotics that shut down most infections offer only limited success with tuberculosis (TB), the leading bacterial cause of death around the world.
Read More →
Page 631 of 878 · Total posts: 10
←First
630
631
632
Last→